|
|
|
|
|
|
|
|
|
Webinar: Maintaining Process Consistency and Performance During N-1 Perfusion Scale-Up
|
Scaling an intensified N-1 perfusion process from bench to pilot scale can present challenges. Drawing on collaborative work conducted across 5 L, 50 L, and 500 L bioreactor scales, experts will share how consistent culture performance, cell growth, and monoclonal antibody production were maintained throughout scale-up. Gain practical insights into the key considerations, challenges, and strategies for successfully transferring intensified upstream processes toward larger-scale manufacturing.
|
|
|
|
FOCUS ON UPSTREAM MANUFACTURING
|
|
|
|
|
|
By Bioprocess Online Live
|
In this segment from the Bioprocess Online Live event, “The Levers And Tradeoffs That Drive Process Productivity,” panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), answer the question, “What should developers be thinking about upstream to avoid downstream complications?” Klyushnichenko believes process-wide considerations like this begin earlier than cell line development at the product’s molecular construct itself.
|
|
|
|
|
|
|
|
CRISPR-Cas9 KO Cell Line Generation And Development
|
|
Article | LICORbio
|
See how CRISPR-generated FKRP knockout muscle cells and a high-throughput On-Cell Western method can quantify α-dystroglycan glycosylation restoration and support rAAV-FKRP potency testing.
|
|
|
|
|
|
|
|
|
|
Producing MSC-Derived Cell Therapies From Isolation To Large-Scale
|
|
White Paper | By Tom Bongiorno, Whitney Cary, Irana Coletti, et al., Corning Life Sciences
|
Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.
|
|
|
|
|
|
|
|
|
|
Automated Enrichment Of Human CD34+ Cells
|
|
Application Note | Miltenyi Biotec
|
Examine an automated strategy for enriching CD34+ cells, combining streamlined processing, strong purity and viability metrics, and reduced hands-on effort to support stem cell engineering.
|
|
|
|
|
|
|
|
|
|
|
|
UPSTREAM MANUFACTURING SOLUTIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Webinar: Scaling ADC manufacturing without compromising quality
|
Scaling ADC programs from clinical to commercial manufacturing brings new challenges in mixing, solvent distribution, hydrophobicity, and process control. This webinar explores practical strategies and digital tools to reduce scale-up risk, including CFD modeling for conjugation, membrane strategies for TFF, and SIMCA®-online for multivariate process control, batch genealogy, and golden batch monitoring. Discover approaches to improve consistency, robustness, and efficiency across ADC manufacturing. Click here to learn more.
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|